US buyout fund Platinum Equity Advisors is in talks to acquire Mumbai-based contract drugmaker Inventia Healthcare at a valuation of ₹2,500 crore ($300 million). Existing investors InvAscent Capital and Jacob Ballas are set to exit their investments while promoter Janak Shah and family will retain a minority stake. Post the transaction, the promoter family intends to continue leading the company. Rothschild & Co and Stifel Financial Corp are running the sale process of Inventia.